BFB Health Limited (HKG:0205)
Hong Kong · Delayed Price · Currency is HKD 0.5050
-0.0450 (-8.18%)
Sep 25, 2026, 3:59 PM HKT
BFB Health Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 638 | 838 | 145 | 294 | 493 | 419 | |
Market Cap Growth | 102.77% | 478.07% | -50.75% | -40.30% | 17.72% | 723.78% |
Enterprise Value | 441 | 758 | 90 | 225 | 456 | 347 |
Last Close Price | 0.51 | 0.67 | 0.17 | 0.35 | 0.59 | 0.60 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 9.46 | 9.46 | 9.46 | 9.46 | 9.46 |
PS Ratio | 2.12 | 25.31 | 4.81 | 7.67 | 6.74 | 6.13 |
PB Ratio | 2.76 | 3.77 | 0.93 | 1.62 | 2.40 | 1.63 |
P/TBV Ratio | 2.95 | 4.03 | 0.83 | 1.42 | 2.27 | 1.60 |
P/FCF Ratio | - | - | 6.32 | - | - | - |
P/OCF Ratio | - | - | 6.29 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.47 | 22.90 | 2.98 | 5.87 | 6.23 | 5.08 |
EV/EBITDA Ratio | 81.52 | - | - | - | 27.57 | 25.55 |
EV/EBIT Ratio | 88.82 | - | - | - | 28.32 | 27.29 |
EV/FCF Ratio | - | - | 3.91 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.13 | 0.26 | 0.19 | 0.20 | 0.05 |
Debt / EBITDA Ratio | 7.48 | - | - | - | 2.38 | 0.99 |
Debt / FCF Ratio | - | - | 1.74 | - | - | - |
Net Debt / Equity Ratio | -0.70 | -0.60 | -0.35 | -0.42 | -0.38 | -0.27 |
Net Debt / EBITDA Ratio | -42.61 | 8.60 | 1.44 | 2.23 | -4.72 | -5.18 |
Net Debt / FCF Ratio | - | 5.61 | -2.34 | 2.07 | 9.98 | 3.08 |
Asset Turnover | 0.65 | 0.09 | 0.09 | 0.10 | 0.16 | 0.14 |
Quick Ratio | 1.07 | 1.27 | 0.97 | 0.98 | 0.92 | 0.94 |
Current Ratio | 1.53 | 2.11 | 2.19 | 2.00 | 1.98 | 2.02 |
Return on Equity (ROE) | -5.12% | -10.57% | -17.15% | -19.32% | -38.62% | -16.82% |
Return on Assets (ROA) | 0.45% | -2.74% | -6.69% | -5.34% | 2.19% | 1.60% |
Return on Capital Employed (ROCE) | 1.40% | -6.60% | -20.70% | -17.10% | 7.10% | 4.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.71% | -0.66% | -23.86% | -7.91% | -16.72% | -9.58% |
FCF Yield | - | -2.85% | 15.83% | -12.50% | -1.59% | -5.45% |
Buyback Yield / Dilution | -49.87% | -30.20% | - | -12.23% | -28.26% | -46.81% |